Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: The INFINITI Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04965935

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-06-09T00:05:00.733936+00:00

Published At

2026-06-08T00:00:00+00:00

Record Updated At

2026-06-08

Results Posted At

2026-06-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Kidney Transplant Recipients", "Post-transplant Diabetes Mellitus", "Type 2 Diabetes"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-06-08"

protocolSection.identificationModule.nctId

"NCT04965935"

protocolSection.identificationModule.officialTitle

"Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: The INFINITI Study"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2026-06-08"

Study condition terms

• Kidney Transplant Recipients (protocolSection.conditionsModule.conditions)
• Post-transplant Diabetes Mellitus (protocolSection.conditionsModule.conditions)
• Type 2 Diabetes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.